GlassScriptPhysician profile
Jose C Chavez
NPI 1629234893
$2,446.91
in general payments reported to CMS, 2019-2025
16 companies · $623 in 2025
The $623 reported for 2025 was more than what 92% of Women'S Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $153).
See the full distribution for Women's Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.08 · 2022: $93.62 · 2023: $627 · 2024: $1,006 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,596.76 | 2023-2025 | Synergy, Avvigo Guidance System, Rotapro |
| Philips North America LLC | $160.86 | 2023 | |
| Baxter Healthcare | $109.83 | 2024 | Starling System |
| Sumitomo Pharma America, INC. | $109.68 | 2024-2025 | Myfembree |
| Masimo Corporation | $72.22 | 2022 | |
| Stryker Corporation | $68.98 | 2025 | Artix Mt |
| Astellas Pharma US INC | $54.38 | 2024-2025 | Veozah |
| Abbvie INC. | $53.44 | 2021 | |
| Organon LLC | $38.63 | 2021-2023 | Nexplanon |
| Sage Therapeutics, LLC | $38.56 | 2025 | Zurzuvae |
| Imperative Care, INC | $32.75 | 2023 | Zoom 88-T Large Distal Platform |
| Glaxosmithkline, LLC. | $30.15 | 2023 | Shingrix |
| Abbott Laboratories | $23.34 | 2021 | |
| Dexcom, INC. | $22.98 | 2023 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $21.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $12.95 | 2023 | Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.